MXPA03006071A - Preparaciones de ciclodextrina. - Google Patents
Preparaciones de ciclodextrina.Info
- Publication number
- MXPA03006071A MXPA03006071A MXPA03006071A MXPA03006071A MXPA03006071A MX PA03006071 A MXPA03006071 A MX PA03006071A MX PA03006071 A MXPA03006071 A MX PA03006071A MX PA03006071 A MXPA03006071 A MX PA03006071A MX PA03006071 A MXPA03006071 A MX PA03006071A
- Authority
- MX
- Mexico
- Prior art keywords
- cyclodextrin
- ebselen
- aqueous solution
- mixing
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
- C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D293/12—Selenazoles; Hydrogenated selenazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Inorganic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion puede proporcionar la siguiente que es una solucion acuosa transparente de una cantidad suficiente de ebselen y utilizable como una inyeccion. Una preparacion con base agua o solucion acuosa que comprende ebselen y ciclodextrina. Una inyeccion que comprende la solucion acuosa. Una infusion intravenosa por goteo que comprende la solucion acuosa. Un proceso para producir una solucion acuosa que contiene ebselen y ciclodextrina, que comprende disolver ebslen en un solvente organico miscible en agua mientras que por separado se disuelve una ciclodextrina en un solvente de agua, mezclar ambas soluciones, despues secar la mezcla y mezclar el producto seco resultante con un solvente de agua. Una preparacion seca que comprende ebselen y ciclodextrina. Un proceso para producir una solucion que contiene ebselen y ciclodextrina, que comprende disolver ebselen en un solvente organico miscible en agua mientras que por separado se disuelve ciclodextrina en un solvente de agua y mezclar ambas soluciones.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001000247 | 2001-01-04 | ||
JP2001016022 | 2001-01-24 | ||
PCT/JP2001/011048 WO2002055076A1 (fr) | 2001-01-04 | 2001-12-17 | Preparation pharmaceutique contenant de la cyclodextrine |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03006071A true MXPA03006071A (es) | 2004-02-26 |
Family
ID=26607336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03006071A MXPA03006071A (es) | 2001-01-04 | 2001-12-17 | Preparaciones de ciclodextrina. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040053888A1 (es) |
EP (1) | EP1348432A4 (es) |
JP (1) | JPWO2002055076A1 (es) |
KR (1) | KR20030068203A (es) |
CN (1) | CN1492760A (es) |
AR (1) | AR032386A1 (es) |
BR (1) | BR0116658A (es) |
CA (1) | CA2434077A1 (es) |
MX (1) | MXPA03006071A (es) |
NO (1) | NO20033042L (es) |
RU (1) | RU2003119972A (es) |
WO (1) | WO2002055076A1 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000058281A1 (fr) | 1999-03-31 | 2000-10-05 | Daiichi Pharmaceutical Co., Ltd. | Substrats pour thioredoxine reductase |
CN1853627B (zh) * | 2005-04-25 | 2011-08-10 | 曾慧慧 | 双苯并异硒唑乙烷环糊精或环糊精衍生物包合物及其制备方法和其用途 |
ZA200800907B (en) | 2005-07-18 | 2010-04-28 | Bipar Sciences Inc | Treatment of cancer |
JP4886233B2 (ja) * | 2005-07-21 | 2012-02-29 | 独立行政法人物質・材料研究機構 | エブセレンの可溶化方法 |
CN100503647C (zh) * | 2005-11-02 | 2009-06-24 | 南京师范大学 | 羟丙基-磺丁基-β-环糊精及其制备方法、分析方法以及在药学上的应用 |
PL1795183T3 (pl) * | 2005-12-09 | 2009-12-31 | Teva Pharma | Wodne dyspersje i roztwory słabo rozpuszczalnych związków oraz sposoby ich wytwarzania |
US20100160442A1 (en) * | 2006-07-18 | 2010-06-24 | Ossovskaya Valeria S | Formulations for cancer treatment |
US8143447B2 (en) | 2006-09-05 | 2012-03-27 | Bipar Sciences, Inc. | Treatment of cancer |
WO2008030891A2 (en) | 2006-09-05 | 2008-03-13 | Bipar Sciences, Inc. | Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof |
CN100411688C (zh) * | 2006-09-12 | 2008-08-20 | 南京师范大学 | 含有环糊精/多烯紫杉醇包合物的药物组合物及其制备方法 |
CN100486645C (zh) * | 2006-09-12 | 2009-05-13 | 南京师范大学 | 含有环糊精紫杉醇包合物的药物组合物及其制备方法 |
RS52633B (en) * | 2007-01-16 | 2013-06-28 | Bipar Sciences Inc. | CANCER TREATMENT FORMULATION |
EP2217227B1 (en) | 2007-11-12 | 2013-08-21 | BiPar Sciences, Inc. | Treatment of breast cancer with 4-iodo-3-nitrobenzamide in combination with anti-tumor agents |
SG173198A1 (en) * | 2009-02-04 | 2011-09-29 | Bipar Sciences Inc | Treatment of lung cancer with a parp inhibitor in combination with a growth factor inhibitor |
GB201102248D0 (en) | 2011-02-09 | 2011-03-23 | Isis Innovation | Treatment of bipolar disorder |
RU2451680C1 (ru) * | 2011-02-21 | 2012-05-27 | Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" | Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство |
WO2015042170A1 (en) | 2013-09-17 | 2015-03-26 | Wayne State University | Compositions and uses of combinations of dim-related indoles and selected anti-androgen compounds |
WO2015071841A1 (en) | 2013-11-12 | 2015-05-21 | Druggability Technologies Holdings Limited | Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
US10576086B2 (en) | 2015-06-12 | 2020-03-03 | University Of Greenwich | Triazine derivatives as interferon-gamma inhibitors |
TWI830180B (zh) * | 2017-06-30 | 2024-01-21 | 財團法人工業技術研究院 | 化合物之液體劑型的醫藥配方 |
WO2021054863A1 (ru) * | 2019-09-18 | 2021-03-25 | Рахимджан Ахметджанович РОЗИЕВ | Стимулятор процессов репаративной регенерации тестикулярной ткани |
WO2023240094A1 (en) * | 2022-06-06 | 2023-12-14 | Sound Pharmaceuticals Inc. | Amorphous dosage form containing ebselen |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01131113A (ja) * | 1987-08-27 | 1989-05-24 | Dai Ichi Seiyaku Co Ltd | 脳障害治療剤 |
US5288734A (en) * | 1988-10-29 | 1994-02-22 | A. Nattermann & Cie Gmbh | Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one and process for producing the same |
AU5780696A (en) * | 1995-06-02 | 1996-12-18 | Takeda Chemical Industries Ltd. | Stabilized composition comprising an antiulcerative benzimid azole |
CA2306465A1 (en) * | 1997-11-07 | 1999-05-20 | Daiichi Pharmaceutical Co. Ltd. | Piperazine-cyclodextrin complexes |
WO2000032230A1 (fr) * | 1998-11-30 | 2000-06-08 | Sankyo Company, Limited | Preparations d'immunoglobuline |
-
2001
- 2001-12-17 JP JP2002555810A patent/JPWO2002055076A1/ja active Pending
- 2001-12-17 US US10/250,472 patent/US20040053888A1/en not_active Abandoned
- 2001-12-17 MX MXPA03006071A patent/MXPA03006071A/es unknown
- 2001-12-17 KR KR10-2003-7009050A patent/KR20030068203A/ko not_active Application Discontinuation
- 2001-12-17 WO PCT/JP2001/011048 patent/WO2002055076A1/ja not_active Application Discontinuation
- 2001-12-17 CN CNA018228720A patent/CN1492760A/zh active Pending
- 2001-12-17 EP EP01273183A patent/EP1348432A4/en not_active Withdrawn
- 2001-12-17 BR BR0116658-1A patent/BR0116658A/pt not_active Application Discontinuation
- 2001-12-17 RU RU2003119972/15A patent/RU2003119972A/ru not_active Application Discontinuation
- 2001-12-17 CA CA002434077A patent/CA2434077A1/en not_active Abandoned
-
2002
- 2002-01-02 AR ARP020100001A patent/AR032386A1/es unknown
-
2003
- 2003-07-02 NO NO20033042A patent/NO20033042L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1348432A4 (en) | 2005-08-10 |
CN1492760A (zh) | 2004-04-28 |
BR0116658A (pt) | 2003-12-30 |
WO2002055076A1 (fr) | 2002-07-18 |
RU2003119972A (ru) | 2004-12-27 |
EP1348432A1 (en) | 2003-10-01 |
NO20033042D0 (no) | 2003-07-02 |
CA2434077A1 (en) | 2002-07-18 |
JPWO2002055076A1 (ja) | 2004-05-13 |
US20040053888A1 (en) | 2004-03-18 |
AR032386A1 (es) | 2003-11-05 |
NO20033042L (no) | 2003-09-04 |
KR20030068203A (ko) | 2003-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03006071A (es) | Preparaciones de ciclodextrina. | |
CN106009001B (zh) | 壳聚糖气凝胶的制备方法 | |
CA2417500A1 (en) | Erbb-2 selective small molecule kinase inhibitors | |
DE69906269T2 (de) | Wässriges verfahren zur herstellung fester paroxetin-dispersionen | |
WO2008043054A3 (en) | Method for producing a low sodium salt composition | |
JP2001089503A5 (es) | ||
DE60117873D1 (de) | Verfahren zur herstellung von submikropartikel-suspensionen pharmazeutischer substanzen | |
TW200724745A (en) | Long-term antibiotic and deodorant textile and preparation method thereof | |
PL1969014T3 (pl) | Sposób modyfikowania skrobi | |
WO2006085957A3 (en) | Polymeric nanocomposites and processes for making the same | |
WO2002022172A3 (en) | Powdered/microfibrillated cellulose | |
KR900701251A (ko) | 약제학적 피막 형성 조성물 | |
WO2005025500A3 (en) | Process for preparing water soluble diterpenes and their applications | |
WO2001060890A3 (fr) | Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leur utilisations | |
MXPA03003533A (es) | Metodo para producir una solucion que consiste en un polimero que contiene unidades azol recurrentes, soluciones producidas de acuerdo con dicho metodo y uso de las mismas. | |
WO2005097201A3 (fr) | Complexes d’inclusions comprenant du piroxicam, une cyclodextrine et l’arginine | |
AR036601A1 (es) | Envase hidrosoluble con colorante fluorescente en la pelicula | |
GB0302673D0 (en) | Pharmaceutical formulations | |
AU2001226867A1 (en) | Cosmetic compositions containing aqueous polymeric dispersions, film-forming in the absence of organic solvent | |
TW200513569A (en) | Aqueous liquid compositions of cyclodextrine or cyclodextrine derivatives and a process using the said composition | |
AU2003233064A1 (en) | Process for the preparation of the amorphous form of atorvastatin calcium salt | |
CN105061608A (zh) | 荧光淀粉纳米晶及其制备方法与应用 | |
AU2003233053A1 (en) | Aqueous liquid compositions of reactive cyclodextrin derivatives and a finishing process using the said composition | |
DK1399138T3 (da) | Fremgangsmåde til fremstilling af faste formuleringer af natrium-3-hydroxy-3-methylbutyrat | |
CN103012607A (zh) | 一种具有高尿素吸附性的双醛多孔淀粉的制备方法 |